Geisinger will expand its precision medicine project beyond research to preventive care, the Danville, PA-based integrated health system announced Sunday. The project already reports clinically actionable genomic results to research participants and their primary care physicians, and plans to launch a clinical DNA pilot program with 1,000 patients in the next six months. “Understanding the genome warning signals of every patient will be an essential part of wellness planning and health management,” Geisinger President and CEO David Feinberg, M.D., told participants at the HLTH Conference in Las Vegas. “Geisinger patients will be able to work with their family physician to modify their lifestyle and minimize risks that may be revealed.”

Related News Articles

Headline
Christine McGuire Chloros, program manager for ChristianaCare's Care for the Caregiver initiative, discusses how the health system has grown its health care…
Chairperson's File
In October 1863, in the middle of the Civil War, President Abraham Lincoln decreed that Thanksgiving be held across the U.S. to “heal the wounds of the nation…
Headline
The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are…
Headline
The Centers for Disease Control and Prevention May 29 published a blog co-authored by AHA, the National Institute for Occupational Safety and Health and the…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…
Blog
Exploring and developing a better understanding of the social determinants of health is becoming standard in medical education and training. Social isolation…